Company intelligence / Profile preview

GlobalLink1 Capital

Phoenix, Arizona, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

GlobalLink1 Capital is a private investment firm focused on private equity, venture capital, strategic financing, private REITs, secured lending, and leveraged investments. The firm appears to operate as a generalist financial investor rather than a biotechnology, pharmaceutical, or healthcare operating company. Publicly available sources describe it as a Phoenix- or Nevada-associated investment organization led by founder and CEO Ron Jankov. There is no clear evidence that GlobalLink1 Capital develops therapeutic products, maintains a drug pipeline, or operates as a life sciences platform company. Accordingly, it is best classified as an investment firm rather than a biotech or healthcare company.

Industry: Investors

Beyond the preview

Go deeper on GlobalLink1 Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GlobalLink1 Capital.

Explore the full profile